Impact of heart failure on quality of sleep

Postgraduate Medical Journal

Volumn 81, Issue 952, 2005, Pages 99-102

  Rao, A ^a   Gray, D ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREATHING; CLINICAL FEATURE; EXERCISE TOLERANCE; FEEDBACK SYSTEM; HEART FAILURE; HUMAN; MORBIDITY; MORTALITY; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; RESPIRATORY FUNCTION; REVIEW; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; UPPER RESPIRATORY TRACT OBSTRUCTION;

CARDIAC OUTPUT, LOW; CHRONIC DISEASE; HUMANS; PROGNOSIS; RESPIRATION; SLEEP APNEA SYNDROMES; SLEEP DISORDERS;

EID: 14144253083     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2003.013300     Document Type: Review

References (59)

1. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53.
2. Schocken DD, Arrieta MI, Leaverton PE. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
3. Sans S, Kesteloot S, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity statistics in Europe. Eur Heart J 1997;18:1231-48.
4. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative North Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1987;316:1429-35.
5. CIBIS 2 investigators and committees. A randomised study: the cardiac insufficiency bisoprolol study 2 (CIBIS 2), Lancet 1999;353:9-13.
6. De Hoyos A, Liu PP, Bernard D. Hemodynamic effects of CPAP in humans with normal and impaired left ventricular function. Clin Sci 1995;88:173-8.
7. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990;82:1724-9.
8. Ferrari R, Ceconi C, Curello S, et al. The neuroendocrine and sympathetic nervous system in congestive heart failure. Eur Heart J 1998;19(suppl F):F45-51.
9. Javaheri S. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995;122:478-92.
10. Kohnlein T, Klante T, Elliott MW, et al. [Heart failure and central respiratory dysregulation. Cheyne-Stokes respiration during sleep in advanced left heart failure]. Pneumologie 2001;55:13-20.
11. Hanly P, Kokhar Z. Increased mortality associated with Cheyne -Stokes respiration. Am J Respir Crit Care Med 1996;153:272-6.
12. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999;99:1435-40.
13. Dampney RA. Central mechanisms underlying short and long term regulation of the cardiovacsular system. Clin Exp Pharmacol Physiol 2002;29:261-8.
14. Prescott E, Hippe M, Schnohr P, et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998;316:1043-7.
15. Kirchheim HR. Systemic arterial baro receptor reflexes. Physiol Rev 1976;56:100-76.
16. Leimbach WN, Wallin BG, Victor RG, et al. Direct evidence from intra neural recordings for increased sympathetic outflow in patients with heart failure. Circulation 1986;73:913-19.
17. Bristow MR, Ginsburg R, Umans V. Beta sub and beta sub 2 adrenergic receptor populations in non failing and failing human ventricular myocardium: coupling of both receptor sub types to muscle contraction and selective beta sub receptor down -regulation in heart failure. Circ Res 1986;59:297-309.
18. Waravdekar NV, Zwillich CW. DISEASEDEX general medicine. In: Gotto A, ed. DISEASEDEX general medicine. [Adapted from Zwillich C: The control of breathing in clinical practice, its significance and assessment.] Colorado: Thomson MICROMEDEX, Green wood Village, 1999.
19. Cooper R. Normal sleep. Cambridge: Chapman and Hall Medical, 1994:3-46.
20. Jouvet M. Recherches sur les structures nerveuses et les mechanismes responsables des differentes phases du sommeil physiologique. Arch Ital Biol 1962;100:125-206.
21. Chase MH, Morales FR. The atonia and muscle active (REM) sleep, Annu Rev Pscychol 1990;41:557.
22. Chapman KR, Bruce N, Gothe B. Possible mechanisms of periodic breathing during sleep. J App Phyisiol 1988;64:1000-8.
23. Kohnlein T. Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax 2002;57:547-54.
24. Krachman S, Ciner GJ. Hypoventilation syndromes. Clin Chest Med 1998;19:139-55.
25. ATS. Indications and standards for cardiopulmonary sleep studies. American Review of Respiratory Disease 1989;139:559-68.
26. Agency for Health care Policy and Research Polysomnography and Sleep Disorders Centre. Health Technol Assess Rep 1991;number 4.
27. Reference withdrawn.
28. Staniforth AD, Kinnear WJ, Starling R, et al. Nocturnal desaturation in patients with stable heart failure. Heart 1997;79:394-9.
29. Reference withdrawn.
30. Fletcher EC, De Behnke RD, Lovoi MS. Undiagnosed sleep apnoea in patients with essential hypertension. Ann Intern Med 1985;103:190-5.
31. Khoo MCK, Gottschal KA, Pack A. Sleep induced periodic breathing and apnoea: a theoretical stud. J Appl Phyisiol 1991;70:2014-24.
32. PM, Young T, Dempsey J. The occurrence of sleep-disordered breathing among middle aged adults. N Engl J Med 1993;328:1230-5.
33. Javaheri S, Parker TJ, Leming JD, et al. Sleep apnoea in 81 ambulatory male patients with stable heart failure. Types and their consequences and presentations. Circulation 1998;97:2154-9.
34. Tremel F, Pepin JL, Veale D, et al. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 1999;20:1201-9.
35. Findley LJ, Zwillich CW, Anconi-Israel S. Cheyne Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 1985;78:11-15.
36. Cherniack NS, Longobardo GS. Cheyne-Stokes breathing :an instability in physiologic control. N Engl J Med 1973;288:952-7.
37. Naughton M, Benard D, Tam A, et al. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. American Review of Respiratory Disease 1993;148:330-8.
38. Weil JV, Bryne-Quinn E, Sodal IE. Augmentation of chemosensitivity during mild exercise in man. J Appl Phyisiol 1972;33:813-19.
39. Swedberg K, Eneroth P, Kjekshus J. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-6.
40. Chua TP, Clarke AL, Amadi AA, et al. Relation between chemo sensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996;27:650-7.
41. Tobin MJ, Snyder P. Cheyne Stokes respiration revisited:controversies and implications. Crit Care Med 1984;12:882-7.
42. Quaranta GE, Dalonzo, Krachman SL. Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 1997;111:467-73.
43. Lange RL, Hecht HH, Mechanism of Cheyne Stokes respiration. J Clin Invest 1962;41:42-52.
44. Hung MJ, Whitford EG, Parsons RW, et al. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;1990:261-4.
45. Palomaki H, Partinen M, Juvela S. Snoring as a risk factor for sleep-related brain infarction. Stroke 1989;20:1311-15.
46. Koskenvuo M, Kaprio J, Telakiwi T, et al. Snoring as a risk factor for ischaemic heart disease and stroke in men. BMJ 1987;294:16-19.
47. Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet 1985;2:1125-6.
48. Hung J, Whitford E, Parsons R. Association of sleep apnoea with myocardial infarction in men. Lancet 1988;336:9-14.
49. Wilcox I, McNamara SG, Wessendorf T, et al. Prognosis and sleep disordered breathing in heart failure. Thorax 1998;53(suppl 3):S33-6.
50. Hanley P, Zuberi Kokhar. Day time sleepiness in patients with congestive heart failure and Cheyne Stokes respiration. Chest 1995;107:952-8.
51. Levine B, Stepanski E, et al. Fragmenting sleep diminishes its recuperative value. Sleep 1987;10:590-9.
52. Staniforth AD, Kinnear WJ, Cowley AJ. Cognitive impairment in heart failure with Cheyne-Stokes respiration. Heart 2000;85:18-22.
53. The task force of the working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997;18:736-53.
54. Javaheri S, Parker TJ, Wexler L. Effect of theophylline on sleep disordered breathing in heart failure. N Engl J Med 1996;335:562-7.
55. Steens RD, Millar TW, Su X. Effect of inhaled 3% CO2 on Cheyne-Stokes respiration in congestive heart failure. Sleep 1994;17:61-8.
56. Hanly P, Millar TW, Steljes DG. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989;111:777-82.
57. Andreas S, Clemens C, Sandholzer H. Improvement of exercise capacity with treatment of Cheyne Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996;27:1486-90.
58. Stoniforth AD, Kinnear WJ, Starling R, et al. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998;19:922-8.
59. Naughton MT, Benard DC, Liu PP, et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995;152:473-9.